QQQ   436.78 (-0.29%)
AAPL   182.52 (-1.00%)
MSFT   410.34 (-0.32%)
META   484.03 (-0.43%)
GOOGL   143.96 (-0.09%)
AMZN   174.99 (+0.23%)
TSLA   191.97 (-2.76%)
NVDA   788.17 (+0.36%)
NIO   5.40 (-7.69%)
AMD   176.52 (-2.94%)
BABA   75.96 (-0.22%)
T   16.80 (+1.27%)
F   12.15 (+0.25%)
MU   86.00 (+0.10%)
CGC   3.36 (-0.30%)
GE   153.33 (+1.09%)
DIS   107.74 (+0.09%)
AMC   4.43 (+0.23%)
PFE   27.76 (+0.76%)
PYPL   59.16 (+1.39%)
XOM   103.84 (-0.88%)
QQQ   436.78 (-0.29%)
AAPL   182.52 (-1.00%)
MSFT   410.34 (-0.32%)
META   484.03 (-0.43%)
GOOGL   143.96 (-0.09%)
AMZN   174.99 (+0.23%)
TSLA   191.97 (-2.76%)
NVDA   788.17 (+0.36%)
NIO   5.40 (-7.69%)
AMD   176.52 (-2.94%)
BABA   75.96 (-0.22%)
T   16.80 (+1.27%)
F   12.15 (+0.25%)
MU   86.00 (+0.10%)
CGC   3.36 (-0.30%)
GE   153.33 (+1.09%)
DIS   107.74 (+0.09%)
AMC   4.43 (+0.23%)
PFE   27.76 (+0.76%)
PYPL   59.16 (+1.39%)
XOM   103.84 (-0.88%)
QQQ   436.78 (-0.29%)
AAPL   182.52 (-1.00%)
MSFT   410.34 (-0.32%)
META   484.03 (-0.43%)
GOOGL   143.96 (-0.09%)
AMZN   174.99 (+0.23%)
TSLA   191.97 (-2.76%)
NVDA   788.17 (+0.36%)
NIO   5.40 (-7.69%)
AMD   176.52 (-2.94%)
BABA   75.96 (-0.22%)
T   16.80 (+1.27%)
F   12.15 (+0.25%)
MU   86.00 (+0.10%)
CGC   3.36 (-0.30%)
GE   153.33 (+1.09%)
DIS   107.74 (+0.09%)
AMC   4.43 (+0.23%)
PFE   27.76 (+0.76%)
PYPL   59.16 (+1.39%)
XOM   103.84 (-0.88%)
QQQ   436.78 (-0.29%)
AAPL   182.52 (-1.00%)
MSFT   410.34 (-0.32%)
META   484.03 (-0.43%)
GOOGL   143.96 (-0.09%)
AMZN   174.99 (+0.23%)
TSLA   191.97 (-2.76%)
NVDA   788.17 (+0.36%)
NIO   5.40 (-7.69%)
AMD   176.52 (-2.94%)
BABA   75.96 (-0.22%)
T   16.80 (+1.27%)
F   12.15 (+0.25%)
MU   86.00 (+0.10%)
CGC   3.36 (-0.30%)
GE   153.33 (+1.09%)
DIS   107.74 (+0.09%)
AMC   4.43 (+0.23%)
PFE   27.76 (+0.76%)
PYPL   59.16 (+1.39%)
XOM   103.84 (-0.88%)
NASDAQ:HQY

HealthEquity (HQY) Stock Price, News & Analysis

$82.23
-0.03 (-0.04%)
(As of 02/23/2024 ET)
Today's Range
$81.85
$83.21
50-Day Range
$63.94
$82.26
52-Week Range
$48.86
$83.86
Volume
503,742 shs
Average Volume
631,896 shs
Market Capitalization
$7.06 billion
P/E Ratio
241.85
Dividend Yield
N/A
Price Target
$83.25

HealthEquity MarketRank™ Stock Analysis

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
6.3% Upside
$87.38 Price Target
Short Interest
Bearish
3.72% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.63mentions of HealthEquity in the last 14 days
Based on 19 Articles This Week
Insider Trading
Selling Shares
$3.38 M Sold Last Quarter
Proj. Earnings Growth
40.54%
From $1.48 to $2.08 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

2.49 out of 5 stars

Medical Sector

502nd out of 939 stocks

Business Services, Not Elsewhere Classified Industry

64th out of 86 stocks


HQY stock logo

About HealthEquity Stock (NASDAQ:HQY)

HealthEquity, Inc. provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts. It also provides mutual fund investment platform; and online-only automated investment advisory services through Advisor, a Web-based tool. In addition, the company offers flexible spending accounts; health reimbursement arrangements; and Consolidated Omnibus Budget Reconciliation Act continuation services, as well as administers pre-tax commuter benefit programs. It serves clients through a direct sales force; benefits brokers and advisors; and a network of health plans, benefits administrators, benefits brokers and consultants, and retirement plan record-keepers. HealthEquity, Inc. was incorporated in 2002 and is headquartered in Draper, Utah.

HQY Stock Price History

HQY Stock News Headlines

HealthEquity price target raised by $13 at RBC Capital, here's why
HealthEquity, Inc.: HealthEquity Reports Year-End Sales Metrics
How to profit from the new boom in gold
Gold just passed $2,000/oz and is set for a new bull run in 2024. Now a renowned precious metals expert is sharing his No. 1 way to play it for just $5. 
HealthEquity Reports Year-End Sales Metrics
HealthEquity Reports Year-End Sales Metrics
HealthEquity (NASDAQ:HQY) Hits New 52-Week High at $82.99
HQY Jun 2024 90.000 put
How to profit from the new boom in gold
Gold just passed $2,000/oz and is set for a new bull run in 2024. Now a renowned precious metals expert is sharing his No. 1 way to play it for just $5. 
HQY Mar 2024 80.000 put
3 Medical Services Stocks to Buy Amid Industry Headwinds
ELV or HQY: Which Is the Better Value Stock Right Now?
See More Headlines
Receive HQY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for HealthEquity and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
12/05/2023
Today
2/23/2024
Next Earnings (Estimated)
3/19/2024
Fiscal Year End
1/31/2025

Industry, Sector and Symbol

Sector
Medical
Industry
Business services, not elsewhere classified
Sub-Industry
N/A
Current Symbol
NASDAQ:HQY
Employees
3,208
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$87.38
High Stock Price Target
$104.00
Low Stock Price Target
$72.00
Potential Upside/Downside
+1.2%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
8 Analysts

Profitability

Net Income
$-26,140,000.00
Pretax Margin
4.67%

Debt

Sales & Book Value

Annual Sales
$861.75 million
Cash Flow
$2.78 per share
Book Value
$22.40 per share

Miscellaneous

Free Float
83,484,000
Market Cap
$7.06 billion
Optionable
Optionable
Beta
0.55
Elon Musk's Next Move Cover

Wondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.

Get This Free Report














HQY Stock Analysis - Frequently Asked Questions

Should I buy or sell HealthEquity stock right now?

8 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for HealthEquity in the last year. There are currently 8 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" HQY shares.
View HQY analyst ratings
or view top-rated stocks.

What is HealthEquity's stock price target for 2024?

8 equities research analysts have issued 1-year target prices for HealthEquity's shares. Their HQY share price targets range from $72.00 to $104.00. On average, they expect the company's share price to reach $87.38 in the next twelve months. This suggests a possible upside of 6.3% from the stock's current price.
View analysts price targets for HQY
or view top-rated stocks among Wall Street analysts.

How have HQY shares performed in 2024?

HealthEquity's stock was trading at $66.30 at the start of the year. Since then, HQY stock has increased by 24.0% and is now trading at $82.23.
View the best growth stocks for 2024 here
.

Are investors shorting HealthEquity?

HealthEquity saw a increase in short interest in January. As of January 31st, there was short interest totaling 3,190,000 shares, an increase of 10.4% from the January 15th total of 2,890,000 shares. Based on an average trading volume of 735,000 shares, the short-interest ratio is presently 4.3 days.
View HealthEquity's Short Interest
.

When is HealthEquity's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, March 19th 2024.
View our HQY earnings forecast
.

How were HealthEquity's earnings last quarter?

HealthEquity, Inc. (NASDAQ:HQY) issued its earnings results on Tuesday, December, 5th. The company reported $0.40 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.32 by $0.08. The business had revenue of $249.22 million for the quarter, compared to analyst estimates of $243.63 million. HealthEquity had a trailing twelve-month return on equity of 5.89% and a net margin of 3.00%.

What guidance has HealthEquity issued on next quarter's earnings?

HealthEquity updated its FY 2025 earnings guidance on Wednesday, February, 21st. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $1.1 billion-$1.2 billion, compared to the consensus revenue estimate of $1.2 billion.

What is Jon Kessler's approval rating as HealthEquity's CEO?

359 employees have rated HealthEquity Chief Executive Officer Jon Kessler on Glassdoor.com. Jon Kessler has an approval rating of 95% among the company's employees. This puts Jon Kessler in the top 30% of approval ratings compared to other CEOs of publicly-traded companies. 69.0% of employees surveyed would recommend working at HealthEquity to a friend.

What other stocks do shareholders of HealthEquity own?

Based on aggregate information from My MarketBeat watchlists, some companies that other HealthEquity investors own include NVIDIA (NVDA), Shopify (SHOP), Block (SQ), Okta (OKTA), PayPal (PYPL), Twilio (TWLO), Trade Desk (TTD), Alibaba Group (BABA), Casino, Guichard-Perrachon Societe Anonyme (COP) and Input Capital (INP).

Who are HealthEquity's major shareholders?

HealthEquity's stock is owned by many different retail and institutional investors. Top institutional investors include Vanguard Group Inc. (10.05%), Wasatch Advisors LP (7.97%), Clearbridge Investments LLC (2.75%), Brown Advisory Inc. (2.11%), Mackenzie Financial Corp (2.11%) and Franklin Resources Inc. (1.73%). Insiders that own company stock include Adrian T Dillon, Angelique Christine Hill, Darcy G Mott, Darcy G Mott, Debra Charlotte Mccowan, Delano Ladd, Edward Bloomberg, Elimelech Rosner, Frank Corvino, Gayle Furgurson Wellborn, Ian Sacks, Jon Kessler, Larry L Trittschuh, Stuart B Parker, Tyson D Murdock and William Robert Otten.
View institutional ownership trends
.

How do I buy shares of HealthEquity?

Shares of HQY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:HQY) was last updated on 2/23/2024 by MarketBeat.com Staff